After ten years, LogMeIn is dropping the free tier of its remote access service. Users will have seven days after their next login to convert to a LogMeIn Pro account, which starts at $99 per year. This change also affects purchasers of the LogMeIn Ignition apps for iOS and Android, which cost up to $149.99 and have been replaced by free apps — the company promises “significant discounts” and “generous terms” to “ease the transition.” LogMeIn’s other products, including join.me and Cubby, are unaffected by this change. follow link
Smarter Parental Controls
If you've been using the parental controls options in Mac OS X to lock your child out of using a particular computer late at night, but would like to employ a more clever technique to limit Internet access, turn to MAC address filtering on an Apple base station.
To do this, launch AirPort Utility, select your base station, and click Manual Setup. In the Access Control view, choose Time Access to turn on MAC filtering. You'll need to enter the MAC address of the particular computer, which (in 10.5 Leopard and 10.6 Snow Leopard) you can find in the Network System Preferences pane: click AirPort in the adapter list, and click Advanced. The AirPort ID is the MAC address.
- ITbits: Mac Remote Desktop Software Roundup (16 Apr 14)
LogMeIn Dropping Free Service
Who gives away their product?
I have used Logmein for years for free and I always wondered why they would give it away.
It did not make any sense to me to give away a great product.
Nevertheless, the way they went about this change will likely end up as a case study in how to make bad business decisions. To send out emails announcing that the free service is gone (and hidden in the fine print is that you have 7 days grace) is the height of business stupidity. Even writing the announcement that the free service WILL be gone in 7 days (with no grace period thereafter) would have been better.
Time will tell, but I think they will have destroyed much trust with their Pro customers - who can see how non-Pro customers were treated and will wonder Who's Next?